Stock Evaluator: Progyny, Inc. (PGNY)

Progyny, Inc. PGNY

$35.71 0.26 0.73%
November 20, 2026 4:00:00 PM EST November 10, 2021 Volume: 1,107,346
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Commentary & Analysis


Financial Summary

Share Statistics PGNY Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $2,629.9 $1,721.2 59%
Shares Out (Mil) 81.2 80.6 57%
Institutional Ownership 98.3% 87.6% 78%
Float (Mil) 67.2 59.2 53%
Beta 0.95 0.74 56%
Avg Daily Volume (000s) 1,045 613 70%
Price Change
(52-week)
40.6% 74.5% 85%
Growth PGNY Industry
Median
Percentile
(All Stocks)
Sales (5yr) 30.2% 10.4% 90%
Net Income (5yr) 4.7% (0.5%) 47%
EPS (5yr) 6.7% 3.0% 42
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (36.1%) (17.4%) 14%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 9 9 9
Current EPS $0.546 $2.113 $2.401
Month Ago EPS $0.525 $2.082 $2.313
# Rev Up 0 0 0
# Rev Down 1 1 1
Three Months Ago EPS $0.526 $2.085 $2.320
Year/Year Chg 70.6% 225.1% 306.6%
Financials PGNY Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1,339 $1,529 53%
Net Income (TTM) (Mil) $91 $33 59%
EPS (TTM) $1.136 $0.300 62%
Operating Cash Flow (TTM) (Mil) $207 $175 59%
Net Cash Flow (TTM) (Mil) ($21) $7 28%
Long-Term Debt (Q1) (Mil) $22 $419 33%
Enterprise Value (Q1) (Mil) $2,396 $2,427 52%
Valuation PGNY Industry
Median
Percentile
(All Stocks)
P/B 6.45 2.56 87%
P/E 33.1 25.9 78%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 4.9 1.1 89%
Ratios PGNY Industry
Median
Percentile
(All Stocks)
Gross Margin 24.9% 27.3% 28%
Net Margin 6.8% 1.4% 53%
ROA 12.4% 2.4% 90%
ROE 18.7% 7.3% 77%
Liabilities to Assets 38.7% 62.3% 29%
F-Score 8 5 93%

Progyny, Inc. did not pass any screens on 11/20/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors